You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
From gene therapy to investment company: What happened to CombiGene?
Text:
Tommie Anderberg | [email protected]
After many years of focus on gene therapy, CombiGene has made a dramatic turnaround. Research has been discontinued, all positions – including the CEO – have been terminated, and the company has been transformed into an investment company...